Skip to main content
Top
Published in: Calcified Tissue International 6/2012

01-12-2012 | Original Research

Temporal Changes in Bone Composition, Architecture, and Strength Following Estrogen Deficiency in Osteoporosis

Authors: Orlaith Brennan, Julia S. Kuliwaba, T. Clive Lee, Ian H. Parkinson, Nicola L. Fazzalari, Laoise M. McNamara, Fergal J. O’Brien

Published in: Calcified Tissue International | Issue 6/2012

Login to get access

Abstract

Using an ovariectomized (OVX) ovine model, we provide an analysis of the timing of changes in bone following estrogen deficiency. The expression of genes known to regulate osteoclastogenesis, matrix production, and mineralization, as measured by real-time RT-PCR, was significantly increased by 12 months; and increased expression was maintained through to 31 months post-OVX compared to controls. FTIR spectroscopy confirmed that mineralized crystals were less mature than in controls 12 months post-OVX and were even less so by 31 months. The mineral-to-matrix ratio was significantly reduced by 31 months, while the ratio of mature to immature collagen cross-linking was initially increased at 12 months and subsequently reduced at 31 months post-OVX. In contrast, trabecular number, thickness, and separation were unchanged at 12 months. Significant reductions in trabecular number and thickness and a significant increase in trabecular separation were observed 31 months after OVX. Most notably perhaps these combined changes led to a significant reduction in the compressive strength of trabecular bone after 31 months. The results indicate that there is an initial increase in bone turnover, which is accompanied by a change in bone composition. This is followed by a continued increase in bone resorption and relative reduction in bone formation, leading to deterioration in bone microarchitecture. Ultimately, these cumulative changes led to a significant reduction in the compressive strength of bones following 31 months of estrogen deficiency. These findings provide important insight into the time sequence of changes during osteoporosis.
Literature
1.
go back to reference Avioli LV (1991) Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy. Calcif Tissue Int 49(2):16–19CrossRef Avioli LV (1991) Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy. Calcif Tissue Int 49(2):16–19CrossRef
2.
go back to reference Parkinson IH, Forbes D, Sutton-Smith P, Fazzalari NL (2010) Model-independent 3D descriptors of vertebral cancellous bone architecture. J Osteoporos 2010:641578PubMed Parkinson IH, Forbes D, Sutton-Smith P, Fazzalari NL (2010) Model-independent 3D descriptors of vertebral cancellous bone architecture. J Osteoporos 2010:641578PubMed
3.
go back to reference Boutroy S, Bouxsein ML, Munoz F, Delmas PD (2005) In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90(12):6508–6515PubMedCrossRef Boutroy S, Bouxsein ML, Munoz F, Delmas PD (2005) In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90(12):6508–6515PubMedCrossRef
4.
go back to reference Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309–319PubMedCrossRef Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309–319PubMedCrossRef
5.
go back to reference McNamara LM, Ederveen AGH, Lyons CG, Price C, Schaffler MB, Weinans H, Prendergast PJ (2006) Strength of cancellous bone trabecular tissue from normal, ovariectomized and drug-treated rats over the course of ageing. Bone 39(2):392–400PubMedCrossRef McNamara LM, Ederveen AGH, Lyons CG, Price C, Schaffler MB, Weinans H, Prendergast PJ (2006) Strength of cancellous bone trabecular tissue from normal, ovariectomized and drug-treated rats over the course of ageing. Bone 39(2):392–400PubMedCrossRef
6.
go back to reference Brennan O, Kennedy OD, Lee TC, Rackard SM, O’Brien FJ (2009) Biomechanical properties across trabeculae from the proximal femur of normal and ovariectomised sheep. J Biomech 42(4):498–503PubMedCrossRef Brennan O, Kennedy OD, Lee TC, Rackard SM, O’Brien FJ (2009) Biomechanical properties across trabeculae from the proximal femur of normal and ovariectomised sheep. J Biomech 42(4):498–503PubMedCrossRef
7.
go back to reference Brennan O, Kennedy OD, Lee TC, Rackard SM, O’Brien FJ, McNamara LM (2011) The effects of estrogen deficiency and bisphosphonate treatment on tissue mineralisation and stiffness in an ovine model of osteoporosis. J Biomech 44(3):386–390PubMedCrossRef Brennan O, Kennedy OD, Lee TC, Rackard SM, O’Brien FJ, McNamara LM (2011) The effects of estrogen deficiency and bisphosphonate treatment on tissue mineralisation and stiffness in an ovine model of osteoporosis. J Biomech 44(3):386–390PubMedCrossRef
8.
go back to reference Brennan M, Gleeson JP, Browne M, O’Brien FJ, Thurner PJ, McNamara LM (2011) Site specific increase in heterogeneity of trabecular bone tissue mineral during estrogen deficiency. Eur Cell Mater 15(21):396–406 Brennan M, Gleeson JP, Browne M, O’Brien FJ, Thurner PJ, McNamara LM (2011) Site specific increase in heterogeneity of trabecular bone tissue mineral during estrogen deficiency. Eur Cell Mater 15(21):396–406
9.
go back to reference Bailey AJ, Sims TJ, Ebbesen EN, Mansell JP, Thomsen JS, Mosekilde L (1999) Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int 65(3):203–210PubMedCrossRef Bailey AJ, Sims TJ, Ebbesen EN, Mansell JP, Thomsen JS, Mosekilde L (1999) Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int 65(3):203–210PubMedCrossRef
10.
go back to reference Bailey AJ, Wotton SF, Sims TJ, Thompson PW (1992) Post-translational modifications in the collagen of human osteoporotic femoral head. Biochem Biophys Res Commun 185(3):801–805PubMedCrossRef Bailey AJ, Wotton SF, Sims TJ, Thompson PW (1992) Post-translational modifications in the collagen of human osteoporotic femoral head. Biochem Biophys Res Commun 185(3):801–805PubMedCrossRef
11.
go back to reference Tran BN, Nguyen ND, Center JR, Eisman JA, Nguyen TV (2009) Enhancement of absolute fracture risk prognosis with genetic marker: the collagen I alpha 1 gene. Calcif Tissue Int 85(5):379–388PubMedCrossRef Tran BN, Nguyen ND, Center JR, Eisman JA, Nguyen TV (2009) Enhancement of absolute fracture risk prognosis with genetic marker: the collagen I alpha 1 gene. Calcif Tissue Int 85(5):379–388PubMedCrossRef
12.
go back to reference Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21(2):195–214PubMedCrossRef Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21(2):195–214PubMedCrossRef
13.
go back to reference Boskey AL (1995) Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci 760:249–256PubMedCrossRef Boskey AL (1995) Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci 760:249–256PubMedCrossRef
14.
go back to reference Hunter GK, Goldberg HA (1993) Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 90(18):8562–8565PubMedCrossRef Hunter GK, Goldberg HA (1993) Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 90(18):8562–8565PubMedCrossRef
15.
go back to reference Tye CE, Rattray KR, Warner KJ, Gordon JA, Sodek J, Hunter GK, Goldberg HA (2003) Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J Biol Chem 278(10):7949–7955PubMedCrossRef Tye CE, Rattray KR, Warner KJ, Gordon JA, Sodek J, Hunter GK, Goldberg HA (2003) Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J Biol Chem 278(10):7949–7955PubMedCrossRef
16.
go back to reference Tye CE, Hunter GK, Goldberg HA (2005) Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction. J Biol Chem 280(14):13487–13492PubMedCrossRef Tye CE, Hunter GK, Goldberg HA (2005) Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction. J Biol Chem 280(14):13487–13492PubMedCrossRef
17.
go back to reference Fantner GE, Hassenkam T, Kindt JH, Weaver JC, Birkedal H, Pechenik L, Cutroni JA, Cidade GA, Stucky GD, Morse DE, Hansma PK (2005) Sacrificial bonds and hidden length dissipate energy as mineralized fibrils separate during bone fracture. Nat Mater 4(8):612–616PubMedCrossRef Fantner GE, Hassenkam T, Kindt JH, Weaver JC, Birkedal H, Pechenik L, Cutroni JA, Cidade GA, Stucky GD, Morse DE, Hansma PK (2005) Sacrificial bonds and hidden length dissipate energy as mineralized fibrils separate during bone fracture. Nat Mater 4(8):612–616PubMedCrossRef
18.
go back to reference Grynpas MD, Tupy JH, Sodek J (1994) The distribution of soluble, mineral-bound, and matrix-bound proteins in osteoporotic and normal bones. Bone 15(5):505–513PubMedCrossRef Grynpas MD, Tupy JH, Sodek J (1994) The distribution of soluble, mineral-bound, and matrix-bound proteins in osteoporotic and normal bones. Bone 15(5):505–513PubMedCrossRef
19.
go back to reference Jilka RL, Takahashi K, Munshi M, Williams DC, Roberson PK, Manolagas SC (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest 101(9):1942–1950PubMedCrossRef Jilka RL, Takahashi K, Munshi M, Williams DC, Roberson PK, Manolagas SC (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest 101(9):1942–1950PubMedCrossRef
20.
go back to reference Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25(7):1468–1486PubMedCrossRef Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25(7):1468–1486PubMedCrossRef
21.
go back to reference Keaveny TM, Borchers RE, Gibson LJ, Hayes WC (1993) Trabecular bone modulus and strength can depend on specimen geometry. J Biomech 26:991–1000PubMedCrossRef Keaveny TM, Borchers RE, Gibson LJ, Hayes WC (1993) Trabecular bone modulus and strength can depend on specimen geometry. J Biomech 26:991–1000PubMedCrossRef
22.
go back to reference Un K, Bevill G, Keaveny TM (2006) The effects of side-artifacts on the elastic modulus of trabecular bone. J Biomech 39(11):1955–1963PubMedCrossRef Un K, Bevill G, Keaveny TM (2006) The effects of side-artifacts on the elastic modulus of trabecular bone. J Biomech 39(11):1955–1963PubMedCrossRef
23.
go back to reference Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11(8):1043–1051PubMedCrossRef Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11(8):1043–1051PubMedCrossRef
24.
go back to reference Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331(16):1056–1061PubMedCrossRef Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331(16):1056–1061PubMedCrossRef
25.
go back to reference Namkung-Matthai H, Appleyard R, Jansen J, Hao Lin J, Maastricht S, Swain M, Mason RS, Murrell GA, Diwan AD, Diamond T (2001) Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28(1):80–86PubMedCrossRef Namkung-Matthai H, Appleyard R, Jansen J, Hao Lin J, Maastricht S, Swain M, Mason RS, Murrell GA, Diwan AD, Diamond T (2001) Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28(1):80–86PubMedCrossRef
26.
go back to reference Turner CH, Forwood MR, Rho JY, Yoshikawa T (1994) Mechanical loading thresholds for lamellar and woven bone formation. J Bone Miner Res 9(1):87–97PubMedCrossRef Turner CH, Forwood MR, Rho JY, Yoshikawa T (1994) Mechanical loading thresholds for lamellar and woven bone formation. J Bone Miner Res 9(1):87–97PubMedCrossRef
27.
go back to reference Wronski TJ, Dann LM, Scott KS, Cintron M (1989) Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45(6):360–366PubMedCrossRef Wronski TJ, Dann LM, Scott KS, Cintron M (1989) Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45(6):360–366PubMedCrossRef
28.
go back to reference D’Amelio P, Grimaldi A, Di Bella S, Brianza SZ, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D, Pescarmona GP, Isaia G (2008) Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 43(1):92–100PubMedCrossRef D’Amelio P, Grimaldi A, Di Bella S, Brianza SZ, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D, Pescarmona GP, Isaia G (2008) Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 43(1):92–100PubMedCrossRef
30.
go back to reference Smith-Mungo LI, Kagan HM (1998) Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 16(7):387–398PubMedCrossRef Smith-Mungo LI, Kagan HM (1998) Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 16(7):387–398PubMedCrossRef
31.
go back to reference Bailey AJ (2002) Changes in bone collagen with age and disease. J Musculoskelet Neuronal Interact 2(6):529–531PubMed Bailey AJ (2002) Changes in bone collagen with age and disease. J Musculoskelet Neuronal Interact 2(6):529–531PubMed
32.
go back to reference Han S, McBride DJ, Losert W, Leikin S (2008) Segregation of type I collagen homo- and heterotrimers in fibrils. J Mol Biol 383(1):122–132PubMedCrossRef Han S, McBride DJ, Losert W, Leikin S (2008) Segregation of type I collagen homo- and heterotrimers in fibrils. J Mol Biol 383(1):122–132PubMedCrossRef
33.
go back to reference Truong LH, Kuliwaba JS, Tsangari H, Fazzalari NL (2006) Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients. Arthritis Res Ther 8(6):R188PubMedCrossRef Truong LH, Kuliwaba JS, Tsangari H, Fazzalari NL (2006) Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients. Arthritis Res Ther 8(6):R188PubMedCrossRef
34.
go back to reference Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier JP, Lajeunesse D (2009) Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 60(5):1438–1450PubMedCrossRef Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier JP, Lajeunesse D (2009) Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 60(5):1438–1450PubMedCrossRef
35.
go back to reference Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE (2009) Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. J Bone Miner Res 24(2):209–220PubMed Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE (2009) Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. J Bone Miner Res 24(2):209–220PubMed
36.
go back to reference Gadeleta SJ, Boskey AL, Paschalis E, Carlson C, Menschik F, Baldini T, Peterson M, Rimnac CM (2000) A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate-treated cynomolgus monkeys (Macaca fascicularis). Bone 27(4):541–550PubMedCrossRef Gadeleta SJ, Boskey AL, Paschalis E, Carlson C, Menschik F, Baldini T, Peterson M, Rimnac CM (2000) A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate-treated cynomolgus monkeys (Macaca fascicularis). Bone 27(4):541–550PubMedCrossRef
37.
go back to reference Busse B, Hahn M, Soltau M, Zustin J, Puschel K, Duda GN, Amling M (2009) Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae. Bone 45(6):1034–1043PubMedCrossRef Busse B, Hahn M, Soltau M, Zustin J, Puschel K, Duda GN, Amling M (2009) Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae. Bone 45(6):1034–1043PubMedCrossRef
38.
go back to reference Ciarelli TE, Fyhrie DP, Parfitt AM (2003) Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 32(3):311–315PubMedCrossRef Ciarelli TE, Fyhrie DP, Parfitt AM (2003) Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 32(3):311–315PubMedCrossRef
39.
go back to reference Kennedy OD, Brennan O, Rackard SM, Staines A, O’Brien FJ, Taylor D, Lee TC (2009) Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. J Orthop Res 27(3):303–309PubMedCrossRef Kennedy OD, Brennan O, Rackard SM, Staines A, O’Brien FJ, Taylor D, Lee TC (2009) Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. J Orthop Res 27(3):303–309PubMedCrossRef
40.
go back to reference Healy C, Kennedy OD, Brennan O, Rackard SM, O’Brien FJ, Lee TC (2010) Structural adaptation and intracortical bone turnover in an ovine model of osteoporosis. J Orthop Res 28(2):248–251PubMed Healy C, Kennedy OD, Brennan O, Rackard SM, O’Brien FJ, Lee TC (2010) Structural adaptation and intracortical bone turnover in an ovine model of osteoporosis. J Orthop Res 28(2):248–251PubMed
41.
go back to reference McKee MD, Nanci A (1996) Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res 35(1–4):197–205PubMedCrossRef McKee MD, Nanci A (1996) Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res 35(1–4):197–205PubMedCrossRef
42.
go back to reference Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21(8):1401–1409PubMedCrossRef Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21(8):1401–1409PubMedCrossRef
43.
go back to reference Young MF, Kerr JM, Ibaraki K, Heegaard AM, Robey PG (1992) Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res 281(281):275–294PubMed Young MF, Kerr JM, Ibaraki K, Heegaard AM, Robey PG (1992) Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res 281(281):275–294PubMed
44.
go back to reference Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317(pt 1):59–64PubMed Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317(pt 1):59–64PubMed
45.
go back to reference Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382(6590):448–452PubMedCrossRef Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382(6590):448–452PubMedCrossRef
Metadata
Title
Temporal Changes in Bone Composition, Architecture, and Strength Following Estrogen Deficiency in Osteoporosis
Authors
Orlaith Brennan
Julia S. Kuliwaba
T. Clive Lee
Ian H. Parkinson
Nicola L. Fazzalari
Laoise M. McNamara
Fergal J. O’Brien
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 6/2012
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-012-9657-7

Other articles of this Issue 6/2012

Calcified Tissue International 6/2012 Go to the issue